Display options
Cite
Das S, Bandyopadhyay S, Ramasamy A, et al. A case of losartan-induced severe hyponatremia. J Pharmacol Pharmacother. 2015;6(4):219-21doi: 10.4103/0976-500X.171880.
Das, S., Bandyopadhyay, S., Ramasamy, A., Prabhu, V. V., & Pachiappan, S. (2015). A case of losartan-induced severe hyponatremia. Journal of pharmacology & pharmacotherapeutics, 6(4), 219-21. https://doi.org/10.4103/0976-500X.171880
Das, Saibal, et al. "A case of losartan-induced severe hyponatremia." Journal of pharmacology & pharmacotherapeutics vol. 6,4 (2015): 219-21. doi: https://doi.org/10.4103/0976-500X.171880
Das S, Bandyopadhyay S, Ramasamy A, Prabhu VV, Pachiappan S. A case of losartan-induced severe hyponatremia. J Pharmacol Pharmacother. 2015 Oct-Dec;6(4):219-21. doi: 10.4103/0976-500X.171880. PMID: 26816476; PMCID: PMC4714391.
Copy Download .nbib Format: NLM
Share it on

J Pharmacol Pharmacother. 2015 Oct-Dec;6(4):219-21. doi: 10.4103/0976-500X.171880.

A case of losartan-induced severe hyponatremia.

Journal of pharmacology & pharmacotherapeutics

Saibal Das, Sanjib Bandyopadhyay, Anand Ramasamy, V Vinoth Prabhu, Sudhakar Pachiappan

Affiliations

  1. Nalmuri Block Primary Health Centre, South 24 Parganas, West Bengal, India.
  2. Department of Community Medicine, Burdwan Medical College and Hospital, Burdwan, West Bengal, India.
  3. Department of Pharmacology, Swamy Vivekanandha College of Pharmacy, Namakkal, Tamil Nadu, India.

PMID: 26816476 PMCID: PMC4714391 DOI: 10.4103/0976-500X.171880

Abstract

This case report outlines a very rare case of losartan-induced severe hyponatremia in a 73-year-old type 2 diabetic patient. The patient was initiated with 50 mg daily oral losartan monotherapy for newly diagnosed moderate hypertension. After 3.5 months of taking the drug, he presented to the emergency department in a drowsy state with severe generalized weakness and occasional palpitations. He was a known diabetic for the last 3 years and well controlled by oral metformin alone. On examination, his serum sodium level was found to be 123 meq/L. There were no evidences of any other possible metabolic, infective, organic or other pathologic causes giving rise to that condition, except losartan itself. De-challenge was done and he was treated vigorously resulting in reversal of the diseased state. Naranjo adverse drug reaction probability scale suggested that it was "probable" that oral losartan was responsible for the development of severe hyponatremia in this patient.

Keywords: AV block; hypertension; hyponatremia; losartan; sodium

References

  1. Hum Exp Toxicol. 2011 Sep;30(9):1409-14 - PubMed
  2. Clin Cardiol. 1991 Feb;14(2):165-8 - PubMed
  3. Electrolyte Blood Press. 2013 Dec;11(2):56-9 - PubMed
  4. J Hum Hypertens. 2002 Sep;16(9):631-5 - PubMed
  5. Clin Pharmacol Ther. 1981 Aug;30(2):239-45 - PubMed

Publication Types